BRI2-mediated regulation of TREM2 processing in microglia and its potential implications for Alzheimer’s disease and related dementias

ITM2B/BRI2 mutations cause familial forms of Alzheimer’s disease (AD)-related dementias by disrupting BRI2’s protein function and leading to the accumulation of amyloidogenic peptides. Although typically studied in neurons, our findings show that BRI2 is highly expressed in microglia, which are crucial in AD pathogenesis due to the association of variants in the microglial gene TREM2 with increased AD risk. Our single-cell RNAseq (scRNAseq) analysis revealed a microglia cluster that depends on a Trem2 activity that is inhibited by Bri2, pointing to a functional interaction between Itm2b/Bri2 and Trem2. Given that the AD-related Amyloid-β Precursor protein (APP) and TREM2 undergo similar proteolytic processing, and that BRI2 inhibits APP processing, we hypothesized that BRI2 may also regulate TREM2 processing. We found that BRI2 interacts with Trem2 and inhibits its processing by α-secretase in transfected cells. In mice lacking Bri2 expression, we observed increased central nervous system (CNS) levels of Trem2-CTF and sTrem2, which are the products of α-secretase processing of Trem2, indicating increased Trem2 processing by α-secretase in vivo. Reducing Bri2 expression only in microglia resulted in increased sTrem2 levels, suggesting a cell-autonomous effect of Bri2 on α-secretase processing of Trem2. Our study reveals a previously unknow role of BRI2 in regulating TREM2-related neurodegenerative mechanisms. The ability of BRI2 to regulate the processing of both APP and TREM2, combined with its cell-autonomous role in neurons and microglia, makes it a promising candidate for the development of AD and AD-related dementias therapeutics.

[1]  Young-Eun Kim,et al.  A Novel c.800G>C Variant of the ITM2B Gene in Familial Korean Dementia. , 2023, Journal of Alzheimer's disease : JAD.

[2]  S. Lichtenthaler,et al.  Secretases in Alzheimer's disease: Novel insights into proteolysis of APP and TREM2 , 2021, Current Opinion in Neurobiology.

[3]  M. Colonna,et al.  Microglia in Alzheimer's disease at single-cell level. Are there common patterns in humans and mice? , 2021, The Journal of experimental medicine.

[4]  Q. Dong,et al.  A Novel ITM2B Mutation Associated with Familial Chinese Dementia. , 2021, Journal of Alzheimer's disease : JAD.

[5]  L. D’Adamio,et al.  Danish and British dementia ITM2b/BRI2 mutations reduce BRI2 protein stability and impair glutamatergic synaptic transmission , 2020, The Journal of biological chemistry.

[6]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[7]  M. Tambini,et al.  Trem2 Splicing and Expression are Preserved in a Human Aβ-producing, Rat Knock-in Model of Trem2-R47H Alzheimer’s Risk Variant , 2020, Scientific Reports.

[8]  A. Fisahn,et al.  Augmentation of Bri2 molecular chaperone activity against amyloid-β reduces neurotoxicity in mouse hippocampus in vitro , 2020, Communications Biology.

[9]  C. Betsholtz,et al.  Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreERT2 lines , 2019, Transgenic Research.

[10]  Yvan Saeys,et al.  A single-cell atlas of mouse brain macrophages reveals unique transcriptional identities shaped by ontogeny and tissue environment , 2019, Nature Neuroscience.

[11]  M. Tambini,et al.  The Familial dementia gene ITM2b/BRI2 facilitates glutamate transmission via both presynaptic and postsynaptic mechanisms , 2019, Scientific Reports.

[12]  J. Trojanowski,et al.  Early increase of CSF sTREM2 in Alzheimer’s disease is associated with tau related-neurodegeneration but not with amyloid-β pathology , 2019, Molecular Neurodegeneration.

[13]  Stephan J Sanders,et al.  Integrative functional genomic analysis of human brain development and neuropsychiatric risks , 2018, Science.

[14]  Fan Zhang,et al.  Fast, sensitive, and accurate integration of single cell data with Harmony , 2018, bioRxiv.

[15]  Lars E. Borm,et al.  Molecular Architecture of the Mouse Nervous System , 2018, Cell.

[16]  D. Holtzman,et al.  High affinity interactions and signal transduction between Aβ oligomers and TREM2 , 2018, bioRxiv.

[17]  Leland McInnes,et al.  UMAP: Uniform Manifold Approximation and Projection for Dimension Reduction , 2018, ArXiv.

[18]  P. S. St George-Hyslop,et al.  TREM2 shedding by cleavage at the H157‐S158 bond is accelerated for the Alzheimer's disease‐associated H157Y variant , 2017, EMBO molecular medicine.

[19]  J. Johansson,et al.  BRICHOS – an anti-amyloid chaperone: evaluation of blood-brain barrier permeability of Bri2 BRICHOS , 2017, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  Lino C. Gonzalez,et al.  TREM2 Binds to Apolipoproteins, Including APOE and CLU/APOJ, and Thereby Facilitates Uptake of Amyloid-Beta by Microglia , 2016, Neuron.

[21]  K. Blennow,et al.  Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer’s disease , 2016, Molecular Neurodegeneration.

[22]  A. Fagan,et al.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status , 2016, Acta Neuropathologica.

[23]  J. Molinuevo,et al.  TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis , 2014, Science Translational Medicine.

[24]  H. Neumann,et al.  Sequential Proteolytic Processing of the Triggering Receptor Expressed on Myeloid Cells-2 (TREM2) Protein by Ectodomain Shedding and γ-Secretase-dependent Intramembranous Cleavage* , 2013, The Journal of Biological Chemistry.

[25]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[26]  A. Singleton,et al.  TREM2 variants in Alzheimer's disease. , 2013, The New England journal of medicine.

[27]  L. D’Adamio,et al.  Inhibition of γ-secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia , 2012, Molecular Neurodegeneration.

[28]  L. D’Adamio,et al.  Memory Deficits of British Dementia Knock-In Mice Are Prevented by Aβ-Precursor Protein Haploinsufficiency , 2012, The Journal of Neuroscience.

[29]  O. Arancio,et al.  β- but not γ-secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia , 2012, Molecular Neurodegeneration.

[30]  E. Snapp,et al.  Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles , 2011, Neurobiology of Aging.

[31]  O. Arancio,et al.  APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant , 2011, The EMBO journal.

[32]  O. Arancio,et al.  Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits , 2010, Proceedings of the National Academy of Sciences.

[33]  Wei Li,et al.  Memory Deficits Due to Familial British Dementia BRI2 Mutation Are Caused by Loss of BRI2 Function Rather than Amyloidosis , 2010, The Journal of Neuroscience.

[34]  B. Ghetti,et al.  Modeling familial British and Danish dementia , 2010, Brain Structure and Function.

[35]  E. McGowan,et al.  BRI2 Inhibits Amyloid β-Peptide Precursor Protein Processing by Interfering with the Docking of Secretases to the Substrate , 2008, The Journal of Neuroscience.

[36]  E. Levy,et al.  Axonal transport of British and Danish amyloid peptides via secretory vesicles , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  P. Vito,et al.  Autosomal Recessive Hypercholesterolemia Protein Interacts with and Regulates the Cell Surface Level of Alzheimer's Amyloid β Precursor Protein* , 2003, Journal of Biological Chemistry.

[38]  K. Blennow,et al.  Intrathecal inflammation precedes development of Alzheimer’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[39]  J. Sutcliffe,et al.  Heterogeneous expression of the triggering receptor expressed on myeloid cells‐2 on adult murine microglia , 2002, Journal of neurochemistry.

[40]  R. Roncarati,et al.  Jun NH2-terminal Kinase (JNK) Interacting Protein 1 (JIP1) Binds the Cytoplasmic Domain of the Alzheimer's β-Amyloid Precursor Protein (APP)* , 2002, The Journal of Biological Chemistry.

[41]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[42]  T Bek,et al.  A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[43]  Agueda Rostagno,et al.  A stop-codon mutation in the BRI gene associated with familial British dementia , 1999, Nature.

[44]  L. D’Adamio,et al.  Increased AβPP processing in familial Danish dementia patients. , 2011, Journal of Alzheimer's disease : JAD.

[45]  P. Davies,et al.  The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. , 2005, The Journal of biological chemistry.